English

UNIGENE LABORATORIES INC

EDGAR

Quarterly report (10-Q) · filed 2013-05-14

89 filing records in this dataset, filed from 1995-05-15 to 2013-05-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

614 thousand USD

2013 Q1 · USD

Exact inputs and evidence

Revenue: 613772 USD Source

Operating margin

-873.45%

2013 Q1 · %

Exact inputs and evidence

Operating Income: -5360991 USD Source
Revenue: 613772 USD Source

Operating cash flow

-3.41 million USD

2013 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -3406209 USD Source

Cash and cash equivalents: 353 thousand USD 2013-03-31 Source
Exact value

353223 USD
Long-term debt including current maturities: 58.3 million USD 2013-03-31 Source
Exact value

58280430 USD
Shares outstanding: 95.2 million shares 2011-12-31 Source
Exact value

95215599 shares

Reported share-count change

2.99% · 2.77 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

92448947 shares · 2010-12-31· Source
95215599 shares · 2011-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

8.3 million USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Revenue: 2737532 USD · 2012-04-01 – 2012-06-30 Source
Revenue: 3412701 USD · 2012-07-01 – 2012-09-30 Source
Revenue: 9438153 USD · 2012-01-01 – 2012-12-31 Source
Revenue: 7901516 USD · 2012-01-01 – 2012-09-30 Source
Revenue: 613772 USD · 2013-01-01 – 2013-03-31 Source

Net income

-29.1 million USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Net income: -11245967 USD · 2012-04-01 – 2012-06-30 Source
Net income: -4502443 USD · 2012-07-01 – 2012-09-30 Source
Net income: -34286210 USD · 2012-01-01 – 2012-12-31 Source
Net income: -18945059 USD · 2012-01-01 – 2012-09-30 Source
Net income: 1978664 USD · 2013-01-01 – 2013-03-31 Source

Operating cash flow

-6.47 million USD

2012-04-01 – 2013-03-31

Exact inputs and evidence

Operating cash flow: -1718648 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -115010 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: -3120657 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -1718648 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: -3177178 USD · 2012-01-01 – 2012-12-31 Source
Operating cash flow: -3120657 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: -3406209 USD · 2013-01-01 – 2013-03-31 Source

Capital expenditure

236 thousand USD

2012-01-01 – 2012-12-31

Exact inputs and evidence

Capital expenditure: 107177 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 140120 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 107177 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 149792 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 140120 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 236355 USD · 2012-01-01 – 2012-12-31 Source
Capital expenditure: 149792 USD · 2012-01-01 – 2012-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-05-14.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2012-12-31
Operating income: 4 of 11 periods available· newest 2012-12-31
Net income: 4 of 11 periods available· newest 2012-12-31
Operating cash flow: 4 of 11 periods available· newest 2012-12-31
Capital expenditure: 4 of 11 periods available· newest 2012-12-31
Total assets: 4 of 11 periods available· newest 2012-12-31
Total liabilities: 4 of 11 periods available· newest 2012-12-31
Current assets: 4 of 11 periods available· newest 2012-12-31
Current liabilities: 4 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2012-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2012-12-31
Shares outstanding: 2 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-54%

Prior period

USD 20.51 million

2011-01-01 – 2011-12-31
Current period

USD 9.44 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

9438153 − 20508346 = -11070193 USD

20508346 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
9438153 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · UNIGENE LABORATORIES INC · 2012-12-31 UNIGENE LABORATORIES INC (edgar:352747) Year-over-year change in Revenue: -11070193 USD Concept: fundies:Revenue Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 9438153 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#195555 Filing: 000143774913002943 Input fundies:Revenue: 20508346 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#195670 Filing: 000143774913002943
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 27.19 million

Prior period

−USD 7.1 million

2011-01-01 – 2011-12-31
Current period

−USD 34.29 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-34286210 − -7095558 = -27190652 USD

-7095558 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-34286210 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · UNIGENE LABORATORIES INC · 2012-12-31 UNIGENE LABORATORIES INC (edgar:352747) Year-over-year change in Net income: -27190652 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -34286210 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#203549 Filing: 000143774913002943 Input fundies:NetIncome: -7095558 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#203676 Filing: 000143774913002943
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 3.59 million

Prior period

−USD 6.77 million

2011-01-01 – 2011-12-31
Current period

−USD 3.18 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

-3177178 − -6766376 = 3589198 USD

-6766376 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
-3177178 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · UNIGENE LABORATORIES INC · 2012-12-31 UNIGENE LABORATORIES INC (edgar:352747) Year-over-year change in Operating cash flow: 3589198 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -3177178 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#229500 Filing: 000143774913002943 Input fundies:OperatingCashFlow: -6766376 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#229684 Filing: 000143774913002943
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-66.3%

Prior period

USD 700,480

2011-01-01 – 2011-12-31
Current period

USD 236,355

2012-01-01 – 2012-12-31

Exact inputs and evidence

236355 − 700480 = -464125 USD

700480 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
236355 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · UNIGENE LABORATORIES INC · 2012-12-31 UNIGENE LABORATORIES INC (edgar:352747) Year-over-year change in Capital expenditure: -464125 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 236355 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#230950 Filing: 000143774913002943 Input fundies:CapitalExpenditure: 700480 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#231132 Filing: 000143774913002943
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

Revenue USD 9.44 million 100% of revenue
Operating costs Derived USD 18.81 million 199% of revenue
Operating income −USD 9.37 million −99% of revenue
Tax, interest and other Derived USD 24.92 million 264% of revenue
Net income −USD 34.29 million −363% of revenue

Cash

Operating cash flow −USD 3.18 million −34% of revenue
Capital expenditure USD 236,355 2.5% of revenue
Free cash flow Derived −USD 3.41 million −36% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Operating loss: operating costs were 197% of revenue.
2010 Operating loss: operating costs were 191% of revenue.
2011 Operating loss: operating costs were 117% of revenue.
2012 Operating loss: operating costs were 199% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	12791838	25171352 Derived	-12379514	1000165 Derived	-13379679	-11510829 Derived	Source 2009-01-01 – 2009-12-31: 12791838 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -12379514 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -13379679 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -11290774 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 220055 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	11340214	21664141 Derived	-10323927	22210024 Derived	-32533951	-1815940 Derived	Source 2010-01-01 – 2010-12-31: 11340214 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -10323927 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -32533951 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -1668521 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 147419 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	20508346	23974575 Derived	-3466229	3629329 Derived	-7095558	-7466856 Derived	Source 2011-01-01 – 2011-12-31: 20508346 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -3466229 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -7095558 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -6766376 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 700480 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	9438153	18809017 Derived	-9370864	24915346 Derived	-34286210	-3413533 Derived	Source 2012-01-01 – 2012-12-31: 9438153 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -9370864 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -34286210 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -3177178 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 236355 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 9.4M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Revenue	12791838	Revenue: 12791838 Open source
20102010-12-31	Revenue	11340214	Revenue: 11340214 Open source
20112011-12-31	Revenue	20508346	Revenue: 20508346 Open source
20122012-12-31	Revenue	9438153	Revenue: 9438153 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-54% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 12791838 Open source
20102010-12-31	Year over year	-11.3%	Revenue: 11340214 Open source Revenue: 12791838 Open source
20112011-12-31	Year over year	80.8%	Revenue: 20508346 Open source Revenue: 11340214 Open source
20122012-12-31	Year over year	-54%	Revenue: 9438153 Open source Revenue: 20508346 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -99.3% 2012

Net margin -363.3% 2012

Free cash flow margin -36.2% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	-96.8%	Operating Income: -12379514 Open source Revenue: 12791838 Open source
20102010-12-31	Operating margin	-91%	Operating Income: -10323927 Open source Revenue: 11340214 Open source
20112011-12-31	Operating margin	-16.9%	Operating Income: -3466229 Open source Revenue: 20508346 Open source
20122012-12-31	Operating margin	-99.3%	Operating Income: -9370864 Open source Revenue: 9438153 Open source
20092009-12-31	Net margin	-104.6%	Net Income: -13379679 Open source Revenue: 12791838 Open source
20102010-12-31	Net margin	-286.9%	Net Income: -32533951 Open source Revenue: 11340214 Open source
20112011-12-31	Net margin	-34.6%	Net Income: -7095558 Open source Revenue: 20508346 Open source
20122012-12-31	Net margin	-363.3%	Net Income: -34286210 Open source Revenue: 9438153 Open source
20092009-12-31	Free cash flow margin	-90%	Revenue: 12791838 Open source Operating Cash Flow: -11290774 Open source Capital Expenditure: 220055 Open source
20102010-12-31	Free cash flow margin	-16%	Revenue: 11340214 Open source Operating Cash Flow: -1668521 Open source Capital Expenditure: 147419 Open source
20112011-12-31	Free cash flow margin	-36.4%	Revenue: 20508346 Open source Operating Cash Flow: -6766376 Open source Capital Expenditure: 700480 Open source
20122012-12-31	Free cash flow margin	-36.2%	Revenue: 9438153 Open source Operating Cash Flow: -3177178 Open source Capital Expenditure: 236355 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3.2M 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Operating cash flow	-11290774	Operating Cash Flow: -11290774 Open source
20102010-12-31	Operating cash flow	-1668521	Operating Cash Flow: -1668521 Open source
20112011-12-31	Operating cash flow	-6766376	Operating Cash Flow: -6766376 Open source
20122012-12-31	Operating cash flow	-3177178	Operating Cash Flow: -3177178 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -3.4M 2012

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Free cash flow	-11510829	Operating Cash Flow: -11290774 Open source Capital Expenditure: 220055 Open source
20102010-12-31	Free cash flow	-1815940	Operating Cash Flow: -1668521 Open source Capital Expenditure: 147419 Open source
20112011-12-31	Free cash flow	-7466856	Operating Cash Flow: -6766376 Open source Capital Expenditure: 700480 Open source
20122012-12-31	Free cash flow	-3413533	Operating Cash Flow: -3177178 Open source Capital Expenditure: 236355 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

972.8% 2012

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Liabilities / assets	227.1%	Total Liabilities: 54396602 Open source Total Assets: 23954941 Open source
20102010-12-31	Liabilities / assets	311.6%	Total Liabilities: 91029926 Open source Total Assets: 29211753 Open source
20112011-12-31	Liabilities / assets	461.1%	Total Liabilities: 83892333 Open source Total Assets: 18195169 Open source
20122012-12-31	Liabilities / assets	972.8%	Total Liabilities: 110052435 Open source Total Assets: 11312901 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.05× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Current assets / current liabilities	0.88×	Current Assets: 9231137 Open source Current Liabilities: 10482138 Open source
20102010-12-31	Current assets / current liabilities	2.2×	Current Assets: 16058038 Open source Current Liabilities: 7300259 Open source
20112011-12-31	Current assets / current liabilities	1.81×	Current Assets: 10290225 Open source Current Liabilities: 5696756 Open source
20122012-12-31	Current assets / current liabilities	0.05×	Current Assets: 5636362 Open source Current Liabilities: 104458198 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	−USD 13.38 million Exact value Exact value: -13379679 USD 2009-01-01 – 2009-12-31: -13379679 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNIGENE LABORATORIES INC · 2009-12-31 UNIGENE LABORATORIES INC (edgar:352747) Net Income: -13379679 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13379679 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913000964/ugne-20111231.xml#36423 Filing: 000143774913000964 The citation records this snapshot. The page link may show a newer release later.	−USD 11.29 million Exact value Exact value: -11290774 USD 2009-01-01 – 2009-12-31: -11290774 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNIGENE LABORATORIES INC · 2009-12-31 UNIGENE LABORATORIES INC (edgar:352747) Operating Cash Flow: -11290774 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11290774 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913000964/ugne-20111231.xml#64484 Filing: 000143774913000964 The citation records this snapshot. The page link may show a newer release later.	USD 220,055 Exact value Exact value: 220055 USD 2009-01-01 – 2009-12-31: 220055 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNIGENE LABORATORIES INC · 2009-12-31 UNIGENE LABORATORIES INC (edgar:352747) Capital Expenditure: 220055 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 220055 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913000964/ugne-20111231.xml#66345 Filing: 000143774913000964 The citation records this snapshot. The page link may show a newer release later.	−USD 11.51 million Calculation and evidence -11290774 − 220055 USD Exact free cash flow: -11510829 USD 2009-01-01 – 2009-12-31: -11290774 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 220055 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNIGENE LABORATORIES INC · 2009-12-31 UNIGENE LABORATORIES INC (edgar:352747) Free cash flow: -11510829 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11290774 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913000964/ugne-20111231.xml#64484 Filing: 000143774913000964 Input fundies:CapitalExpenditure: 220055 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913000964/ugne-20111231.xml#66345 Filing: 000143774913000964 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 32.53 million Exact value Exact value: -32533951 USD 2010-01-01 – 2010-12-31: -32533951 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNIGENE LABORATORIES INC · 2010-12-31 UNIGENE LABORATORIES INC (edgar:352747) Net Income: -32533951 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32533951 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#203802 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.	−USD 1.67 million Exact value Exact value: -1668521 USD 2010-01-01 – 2010-12-31: -1668521 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNIGENE LABORATORIES INC · 2010-12-31 UNIGENE LABORATORIES INC (edgar:352747) Operating Cash Flow: -1668521 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1668521 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#229868 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.	USD 147,419 Exact value Exact value: 147419 USD 2010-01-01 – 2010-12-31: 147419 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNIGENE LABORATORIES INC · 2010-12-31 UNIGENE LABORATORIES INC (edgar:352747) Capital Expenditure: 147419 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 147419 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#231314 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.	−USD 1.82 million Calculation and evidence -1668521 − 147419 USD Exact free cash flow: -1815940 USD 2010-01-01 – 2010-12-31: -1668521 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 147419 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNIGENE LABORATORIES INC · 2010-12-31 UNIGENE LABORATORIES INC (edgar:352747) Free cash flow: -1815940 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1668521 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#229868 Filing: 000143774913002943 Input fundies:CapitalExpenditure: 147419 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#231314 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 7.1 million Exact value Exact value: -7095558 USD 2011-01-01 – 2011-12-31: -7095558 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNIGENE LABORATORIES INC · 2011-12-31 UNIGENE LABORATORIES INC (edgar:352747) Net Income: -7095558 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7095558 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#203676 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.	−USD 6.77 million Exact value Exact value: -6766376 USD 2011-01-01 – 2011-12-31: -6766376 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNIGENE LABORATORIES INC · 2011-12-31 UNIGENE LABORATORIES INC (edgar:352747) Operating Cash Flow: -6766376 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6766376 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#229684 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.	USD 700,480 Exact value Exact value: 700480 USD 2011-01-01 – 2011-12-31: 700480 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNIGENE LABORATORIES INC · 2011-12-31 UNIGENE LABORATORIES INC (edgar:352747) Capital Expenditure: 700480 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 700480 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#231132 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.	−USD 7.47 million Calculation and evidence -6766376 − 700480 USD Exact free cash flow: -7466856 USD 2011-01-01 – 2011-12-31: -6766376 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 700480 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNIGENE LABORATORIES INC · 2011-12-31 UNIGENE LABORATORIES INC (edgar:352747) Free cash flow: -7466856 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6766376 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#229684 Filing: 000143774913002943 Input fundies:CapitalExpenditure: 700480 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#231132 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 34.29 million Exact value Exact value: -34286210 USD 2012-01-01 – 2012-12-31: -34286210 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNIGENE LABORATORIES INC · 2012-12-31 UNIGENE LABORATORIES INC (edgar:352747) Net Income: -34286210 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34286210 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#203549 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.	−USD 3.18 million Exact value Exact value: -3177178 USD 2012-01-01 – 2012-12-31: -3177178 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNIGENE LABORATORIES INC · 2012-12-31 UNIGENE LABORATORIES INC (edgar:352747) Operating Cash Flow: -3177178 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3177178 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#229500 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.	USD 236,355 Exact value Exact value: 236355 USD 2012-01-01 – 2012-12-31: 236355 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNIGENE LABORATORIES INC · 2012-12-31 UNIGENE LABORATORIES INC (edgar:352747) Capital Expenditure: 236355 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 236355 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#230950 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.	−USD 3.41 million Calculation and evidence -3177178 − 236355 USD Exact free cash flow: -3413533 USD 2012-01-01 – 2012-12-31: -3177178 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 236355 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNIGENE LABORATORIES INC · 2012-12-31 UNIGENE LABORATORIES INC (edgar:352747) Free cash flow: -3413533 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:00:36Z Snapshot: 79f940f71a7143d5ef1c09235c6a0e2e7e3cd34a55d4b29c2b46f7ced1bf73cc Dimensions: Consolidated View: https://fundies.io/companies/edgar/352747?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3177178 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#229500 Filing: 000143774913002943 Input fundies:CapitalExpenditure: 236355 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352747/000143774913002943/ugne-20121231.xml#230950 Filing: 000143774913002943 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

89 filings · 762 latest values · 762 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000352747, 352747, edgar:352747

Also known as UNIGENE LABORATORIES INC

UNIGENE LABORATORIES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2012 2012-01-01 – 2012-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation